Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
Contact Us
EMJ Gold
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
February 2017
EMJ Dermatology 5 [Suppl 3] 2017
Este seminario especializado financiado mediante una contribución independiente realizada por OM/Vifor Pharma reunió a facultativos especializados…
21
Mins
13th February 2017
Insuficiencia venosa crónica: manejo y tratamiento
La EVC es una enfermedad preocupante que genera una carga significativa sobre los servicios sanitarios y la sociedad en general.
15
Mins
13th February 2017
Chronic Venous Insufficiency: Management and Treatment
CVD is a very concerning condition which creates a significant burden on healthcare provision and wider society. Varicose veins are often the first sign of CVD.
1
Mins
10th February 2017
A New Treatment Option for Malaria?
THE DISCOVERY of a protein that assists parasites in attacking human red blood cells could be used to develop more developed vaccines for the disease…
5
Mins
10th February 2017
BIAL and Neurocrine Announce Exclusive North American Licensing Agreement for Opicapone
Porto, Portugal and San Diego, California, February 10, 2017 – BIAL and Neurocrine Biosciences, Inc. (NASDAQ: NBIX) today announced that they have…
1
Mins
10th February 2017
New Blood Test Creates Optimism for Bone Marrow Transplant Patients
A BLOOD TEST to help predict the risk of non-relapse mortality (NRM) and severe graft-versus-host disease (GVHD) in blood cancer patients who undergo a…
1
Mins
9th February 2017
Merlin Protein Could Help Peripheral Nerves Repair Themselves
RESEARCHERS have learnt how a particular protein enables damaged nerves to repair themselves in a study using mouse models. The findings of this research…
1
Mins
7th February 2017
Microgreen Consumption May Lower Cardiovascular Risk
MICROGREENS, seedlings of plants often used as up-market garnishes, may be the key to better cardiovascular protection and lower levels of circulating…
1
Mins
7th February 2017
The Potential of SHP-1 Control in the Maintenance of Stent Patency
SURGICAL STENT implantation within Type 2 diabetes mellitus (T2DM) patients is an operation of limited long-term success, due to the accelerated rate at…
1
Mins
6th February 2017
Mechanical Force Used by Antibiotics to ‘Tear Apart’ Resistant Bacteria
SCIENTISTS have found that antibiotics are still able to kill resistant bacteria by using mechanical force to ‘tear holes in the bacteria and rip them…
←
1
2
3
…
714
715
716
717
718
719
720
…
897
898
899
→